Evidence map›Paper›PMID 26309021›Full record

ArticleInternational journal of clinical and experimental medicine2015

Vascular risk factors aggravate the progression of Parkinson's disease: a five-year follow-up study in Chinese patients.

Hai Jun Li, Ying Yu, Ying Chen, Hai Yan Liang

Abstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hai Jun LiDepartment of Neurology, Municipal Hospital of Taizhou Jiaojiang 318000, Zhejiang, People's Republic of China.
Ying YuDepartment of Neurology, Municipal Hospital of Taizhou Jiaojiang 318000, Zhejiang, People's Republic of China.
Ying ChenDepartment of Neurology, Municipal Hospital of Taizhou Jiaojiang 318000, Zhejiang, People's Republic of China.
Hai Yan LiangDepartment of Neurology, Municipal Hospital of Taizhou Jiaojiang 318000, Zhejiang, People's Republic of China.
Taizhou Municipal Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSome studies have found that vascular risk factors were related to an increased risk of Parkinson's disease. In order to investigate the comorbidities of the vascular risk factors with PD and their impact on PD progression, we launched a five-year follow-up study in 247 outpatients with probable PD.

methodsThe incidence of vascular risk factors including hypertension, diabetes, hypercholesterolemia, hyperhomocysteinemia and carotid atherosclerotic plaque analyzed. The Hoen and Yahr score with and without vascular risk factors were compared at initial and at final evaluation.

resultsMultiple regression analysis showed that age, hypertension and hyperhomocysteinemia were significant variables that are associated with the Hoen and Yahr scales. Younger patients with hypertension or hyperhomocysteinemia showed a greater increasing in the Hoen and Yahr score. There were no significant correlations among the Hoen and Yahr score with sex, initial of the Hoen and Yahr score, diabetes, hypercholesterolemia or carotid atherosclerotic plaque.

conclusionThe vascular risk factors are common comorbidities of PD. Younger, more educated patients are more likely to have quicker dyskinesia decline. In addition, hypertension and hyperhomocysteinemia may aggravate the progression of PD. The prevention and treatment of hypertension and hyperhomocysteinemia are important for PD patients.

Indexed as

cognitionParkinson’s diseaseprogressionvascular risk factors

Identifiers

PMID26309021
PMCPMC4537966
OpenAlexW1178267799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.